Atrophic gastritis is associated with increased sucrose permeability related to chronic inflammation

Digestion

Volumn 72, Issue 4, 2005, Pages 201-206

  Zsigmond, Camilla Sjöstedt ^a   Hannestad, Ulf ^a   Franzén, Lennart ^b   Söderholm, Johan D ^a   Borch, Kurt ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atrophy; Gastric mucosal barrier; Intestinal metaplasia; Sucrose permeability

Indexed keywords

SUCROSE;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENDOSCOPIC BIOPSY; EXPOSURE; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MALE; MASS SPECTROMETRY; MULTIVARIATE ANALYSIS; PERMEABILITY; PRIORITY JOURNAL; STOMACH ANTRUM; STOMACH MUCOSA; URINARY EXCRETION;

ADULT; AGED; AGED, 80 AND OVER; CELL MEMBRANE PERMEABILITY; DISEASE PROGRESSION; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GASTRIC MUCOSA; GASTRITIS, ATROPHIC; HUMANS; MALE; METAPLASIA; MIDDLE AGED; PROGNOSIS; SUCROSE; SWEETENING AGENTS;

EID: 29244437190     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089145     Document Type: Article

References (32)

1. Kuipers E, Klinkenberg-Knol JC, Vandenbroucke-Grauls CM, Appelmelk BJ, Schenk BE, Meuwissen SG: Role of Helicobacter pylori in the pathogenesis of atrophic gastritis. Scand J Gastroenterol Suppl 1997;223:28-34.
2. Negrini R, Savio A, Poiesi C, Appelmelk BJ, Buffoli F, Paterlini A, Cesari P, Graffeo M, Vaira D, Franzin G: Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 1996;111:655-665.
3. Sanduleanu S, Jonkers D, De Bruine A, Hameeteman W, Stockbrugger RW: Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-supppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis. Aliment Pharmacol Ther 2001;15:1163-1175.
4. Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S, Castro Alves C, Campos ML, Van Doorn LJ, Caldas C, Seruca R, Carneiro F, Sobrinho-Simoes M: A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003;125:364-371.
5. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H: Interleukin 1 beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrance in Japan. Gastroen-terology 2002;123:92-105.
6. Zamcheck N, Grable E, Ley A, Norman L: Occurance of gastric cancer among patients with pernicious anemia at the Boston City Hospital. N Engl J Med 1955;252:1103-1110.
7. Siurala M, Lehtola J, Ihamäki T: Atrophic gastritis and its sequelae: results of 19-23 years follow-up examinations. Scand J Gastroenterol 1974;9:441-446.
8. Correa P: Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735-6740.
9. Borch K, Kullman E, Hallhagen S, Ledin T, Ihse I: Increased incidence of pancreatic neoplasia in pernicious anemia. World J Surg 1988;12:866-870.
10. Hsing A, Hansson LE, McLaughlin JK, Nyren O, Blot WJ, Ekbom A, Fraumeni JF: Pernicious anemia and subsequent cancer: a population-based cohort study. Cancer 1993;71:745-750.
11. Borch K, Renvall H, Liedberg G: Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology 1985;88:638-648.
12. Sjöblom SM, Sipponen P, Miettinen M, Karonen SL, Järvinen HJ: Gastroscopic screening for gastric carcinoids and carcinoma in pernicious anemia. Endoscopy 1988;20:52-56.
13. Söderholm JD, Olaison G, Franzén L, Borch K: Increased gastric absoiption of polyethylene glycols in atrophic gastritis. Digestion 1996;57:191-195.
14. Meddings JB, Lloyd R, Sutherland LR, Byles NI, Wallace JL: Sucrose: a novel permeability marker for gastroduodenal disease. Gastroenterology 1993;104:1619-1626.
15. Sutherland LR, Verhoef M, Wallace JL, Van Rosendaal G, Crutcher R, Meddings JB: A simple non-invasive marker of gastric damage: sucrose permeability. Lancet 1994;343:998-1000.
16. Borch K, Sjöstedt C, Hannestad U, Söderholm JD, Franzén L, Mårdh S: Asymptomatic Helicobacter pylori gastritis is associated with increased sucrose permeability. Dig Dis Sci 1998;43:749-753.
17. Borch K, Liedberg G: Prevalence and incidence of pernicious anemia. An evaluation for gastric screening. Scand J Gastroenterol 1984;19:154-160.
18. Borch K, Jönsson KÅ, Petersson F, Redéen S, Mårdh S, Franzén L: Prevalence of gastroduodenitis and Helicobacter pylori infection in a general population sample. Dig Dis Sci 2000;45:1322-1329.
19. Price A: The Sydney system: histological division. J Gastroenterol Hepatol 1991;6:209-222.
20. Ciucanu I, Kerek F: A simple and rapid method for the permethylation of carbohydrates. Carbohydr Res 1984;131:209-217.
21. Smecuol E, Bai JC, Vazquez H, Kogan Z, Cabanne A, Niveloni S, Pedreira S, Boerr L, Maurino E, Meddings JB: Gastrointestinal permeability in coeliac disease. Gastroenterology 1997;112:1129-1136.
22. Tosetti C, Stanghellini V, Tucci A, Poli L, Salvioli B, Biasco G, Paparo GF, Levorato M, Corinaldesi R: Gastric emptying and dyspeptic symptoms in patients with nonautoimmune fundic atrophic gastritis. Dig Dis Sci 2000;45:252-257.
23. Da Rocha AF, Zuccaro AM, Marquiotti M: Relationship between severity of clinical symptoms and delay in gastric emptying in chronic gastritis; studied with 99mTc-DTPA scintigraphy. Eur J Nucl Med 1986;12:91-95.
24. Tucci A, Poli L, Biasco G, Paparo GF, Tosetti C, Fusaroli P, Sambri V, Donati M, Grigioni W, Labate AM, Stanghellini V, Caletti G: Helicobacter pylori infection and gastric function in patients with fundic atrophic gastritis. Dig Dis Sci 2001;46:1573-1583.
25. Molinari F, Parodi MC, De Angelis P, Cheli R: Gastric mucus secretion in chronic gastritis. Scand J Gastroenterol Suppl 1984;92:167-171.
26. Bjarnarsson I, MacPherson A, Hollander D: Intestinal permeability: an overview. Gastroenterology 1995;108:1566-1581.
27. Madara JL, Parkos C, Colgan S, Nusrat A, Atisook K, Kauotzani P: The movement of solutes and cells across tight junctions. Ann NY Acad Sci 1992;664:47-60.
28. Von Ritter C, Grisham MB, Hollwarth M, Inauen W, Granger DN: Neutrophil-derived oxidants mediate formyl-methionyl-leucyl-phenylalanine- induced increases in mucosal permeability in rats. Gastroenterology 1989;97:778-780.
29. Posalaki Z, Posalaki I, McGinley D, Meyer RA: The gastric mucosal barrier: tight junction structure in gastritis and ulcer biopsies. Virchows Arch A Pathol Anal Histopathol 1989; 414:217-222.
30. Sugimura T, Matsukura N, Sato S: Intestinal metaplasia of the stomach as a precancerous stage. IARC Sci Publ 1982;39:515-530.
31. Petersson F, Borch K, Franzén LE: Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis. Scand J Gastroenterol 2002;37:262-266.
32. Talley NJ, Chute CG, Larson DE, Epstein R, Lydick EG, Melton LJ: Risk for colorectal adenocarcinoma in pernicious anemia. A population-based cohort study. Ann Intern Med 1989;111:738-742.